Skip to main content
. 2021 Jul 16;12(7):1080. doi: 10.3390/genes12071080

Table 3.

BRAF concordance analysis.

Patient No Tumor Liquid Biopsy 1 Liquid Biopsy 2
P/M 1 qPCR NGS VAF 2 % NGS VAF % NGS VAF %
1 M V600 V600E 48.6 V600E 7.0 V600E 93.0
2 M V600 V600E 18.7 V600E 25.0 V600E 35.0
3 M V600 V600E 37.5 V600E 2.5 V600E 5.2
4 M WT 3 WT 0.0 WT 0.0 WT 0.0
5 M V600 NA 4 - V600E 35.0 WT 0.0
6 P V600 V600E 43.9 V600E 43.2 NA
7 M V600 V600E 31.4 V600E 0.7
8 P WT WT 0.0 WT 0.0
9 P V600 WT * 0.0 V600E 0.3
10 P V600 V600E 50.7 V600E 16.8
11 P WT WT 0.0 WT 0.0
12 P V600 V600R 33.0 V600R 0.2
13 M V600 NA - V600E 6.4
14 P V600 NA - WT * 0.0

1 P/M—primary tumor/metastasis; 2 VAF—variant allele frequency; 3 WT—wild type; 4 NA—not analyzed; discordant results are marked with an asterisk.